Search for: "In Re Joint E. & S. Dists. Asbestos Litigation"
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
19 Jun 2010, 9:15 am
See In re Joint E. [read post]
26 Feb 2012, 10:31 am
Pa. 1996), rev’d, 148 F.3d 242 (3d Cir. 1997) Asbestos In re Joint E. [read post]
20 Aug 2010, 4:25 am
Asbestos Litig., 134 F.R.D. 32, 37 (E. [read post]
22 Mar 2010, 4:13 am
See In re Joint E. [read post]
3 Mar 2012, 5:36 pm
Pittsburgh Corning Corp., 127 N.J. 428, 605 A.2d 1092 (1992) In re Joint E. [read post]
7 Mar 2009, 10:31 pm
In re Joint E. [read post]
18 Mar 2011, 10:04 am
Pittsburgh Corning Corp., 127 N.J. 428, 605 A.2d 1092 (1992) In re Joint E. [read post]
31 Jul 2017, 7:00 am
In re Zoloft Prod. [read post]
5 Jun 2013, 5:29 am
Supp. 247 (1984), rev’d on other grounds, 816 F.2d 1417 (10th Cir. 1987) In re TMI Litig., 927 F. [read post]
8 Jul 2012, 10:58 am
Asbestos Litig., 827 F. [read post]
25 Apr 2015, 11:03 am
For example, in some litigations, plaintiffs will rely upon high-dose or high-exposure studies that are not comparable to the plaintiff’s actual exposure, and the defense may have shown that the only reliable evidence is that there is a small (relative risk less than two) or no risk at all from the plaintiff’s exposure. [read post]
17 Oct 2021, 2:17 pm
INTRODUCTION The new, third edition of the Reference Manual on Scientific Evidence was released to the public in September 2011, as a joint production of the National Academies of Science, and the Federal Judicial Center. [read post]
14 Nov 2011, 7:13 pm
” In In re Joint E. [read post]
22 Jan 2009, 2:06 am
As do almost all plaintiffs in prescription drug product liability litigation, she claimed that the drug's label failed to warn adequately of this risk. [read post]
